Rivaroxaban API Manufacturers and Suppliers in India
Rivaroxaban API is an important pharmaceutical compound used as an oral anticoagulant to prevent and treat blood clots. It works by inhibiting Factor Xa, which helps prevent conditions like deep vein thrombosis, pulmonary embolism, and stroke in patients with atrial fibrillation. It is a key Active Pharmaceutical Ingredient (API) in the healthcare industry.
Description
Name of the product: Rivaroxaban
Chemical Name : (S)-5-chloro-N-{[2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl} thiophene-2-carboxamide
Molecular weight: 435.89 g/mol
Molecular formula: C19H18CIN3O5S
Category: Xa inhibitors
Therapeutic use: Anticoagulant used to prevent and treat blood clots
Usage: To reduce risk of conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE)
Physical Form: Powder
Color: White or yellow
Package: As per requirement
Storage: Store in air-tight container below 30 deg C
Synonyms: 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
Solubility: Practically insoluble in water, freely soluble in dimethyl sulfoxide, practically insoluble in anhydrous ethanol and in heptanes
Specification
- Assay: 98.0% – 102.0% w/w (anhydrous substance)
- Total impurities: maximum 0.3%
- Unspecified impurity: maximum 0.1%
The Rivaroxaban API specification ensures that each batch of Rivaroxaban meets global quality standards. As one of the top Rivaroxaban API manufacturers in India, Bio-Synth adheres to strict guidelines to ensure product purity and properties.
Applications of Rivaroxaban API
- Rivaroxaban can help prevent strokes in patients with nonvalvular atrial fibrillation (NVAF) by helping to prevent clots from forming
- Rivaroxaban is used to treat blood clots in the veins of the legs (deep vein thrombosis or DVT) or lungs (pulmonary embolism or PE)
Therapeutic Uses and Indications
☐ Used to reduce the risk of blood clots from happening again in adults who continue to be at risk for DVT or PE after receiving treatment for blood clots for at least 6 months
☐ Used to help prevent a blood clot in the legs and lungs of adults who have just had hip or knee replacement surgery
☐ Used to help prevent blood clots in certain adults hospitalized for an acute illness and after discharge, who are at risk of getting blood clots because of the loss of or decreased mobility and other risks for getting blood clots, and who do not have a high risk of bleeding
It also has cardiovascular applications and is used with low dose aspirin to:
☐ Reduce the risk of serious heart problems, heart attack, and stroke in adults with coronary artery disease (a condition where the blood supply to the heart is reduced or blocked)
☐ Reduce the risk of a sudden decrease in blood flow to the legs, major amputation, serious heart problems, or stroke in adults with peripheral artery disease (a condition where the blood flow to the legs is reduced) and includes adults who have recently had a procedure to improve blood flow to the legs
How Rivaroxaban Works (Mechanism of Action)
Rivaroxaban prevents factor Xa from activating prothrombin to thrombin. Thrombin is a serine protease that activates fibrinogen to fibrin, which completes the clotting process. By preventing factor Xa from working, rivaroxaban thins the blood, making it take longer to clot.
Quality Standards and Manufacturing Excellence
Bio-Synth operates with an unwavering commitment to quality. Our manufacturing processes integrate
☐ WHO-GMP (Good Manufacturing Practices) compliance
☐ ISO 9000:2015 certification
☐ Adherence to ICH guidelines and pharmacopeia standards
Our facilities are equipped with cutting-edge technology and maintain strict adherence to GLP (Good Laboratory Practices), GDP (Good Documentation Practices), and cGMP (Current Good Manufacturing Practices). This results in consistent product quality, reinforcing Bio-Synth’s reputation for excellence.
Why Choose Bio-Synth for Rivaroxaban API
Bio-Synth adheres to stringent quality protocols to ensure that each batch of Rivaroxaban meets comprehensive global quality standards. Our robust quality control practices confirm the purity, potency, and safety of our products, ensuring reliable therapeutic results. Our 120kL WHO-GMP, ISO certified facility has a capacity to manufacture 1 MT of Rivaroxaban per month. Bio-synth manufacturers all intermediates of Rivaroxaban in-house, ensuring superior quality, price, and delivery schedules.
Advantages and Key Features of Rivaroxaban API
- Proven efficacy as a direct oral anticoagulant, with predictable anticoagulant effect and no routine coagulation monitoring required
- Has a rapid onset of action, with a Cmax of 2 to 4 hours.
- Has few drug interactions, no dietary interactions, is easy to use, is well tolerated and has superior safety in regard to bleeding events compared to Warfarin
- Has demonstrated equivalence, or in some cases, superiority to Warfarin in preventing stroke or systemic embolism.
Rivaroxaban API Suppliers and Manufacturers in India
As one of the leading manufacturers of Rivaroxaban in India, Bio-synth manufactures all intermediates in-house, enabling the highest quality, most competitive prices, and shortest lead times. With 81 years of manufacturing experience, our processes and systems are optimized to deliver the best quality product that matches your requirements
Rivaroxaban API price in India
The price of Rivaroxaban API provided by Bio-Synth depends on several factors, including order quantity, quality standards, and current market conditions. To get an accurate and customised quote, it’s best to contact Bio-Synth us directly, as we ensure competitive pricing and adherence to regulatory standards.
Frequently asked questions
We are listening.
We believe that the heart of dialogue is listening. Please write in your queries and we will get back to you.
- Rivaroxaban is an anticoagulant that is used to treat blood clots in the veins of the legs (deep vein thrombosis or DVT) or lungs (pulmonary embolism or PE)
- Rivaroxaban can help prevent strokes in patients with nonvalvular atrial fibrillation (NVAF) by helping to prevent clots from forming
Bio-Synth stands out as a trusted Rivaroxaban manufacturer in India due to its strict adherence to global standards, such as WHO-GMP and ISO 9000:2015 certifications. We focus on high-quality, reliable production, offering competitive pricing and customizable solutions. Our robust quality control and consistent supply make Bio-Synth a dependable partner for pharmaceutical companies needing top-quality Rivaroxaban
Bio-Synth adheres to stringent quality protocols to ensure that each batch of Rivaroxaban meets comprehensive global quality standards. Our WHO-GMP and ISO 9000:2015 facility is equipped with cutting-edge technology and maintains strict adherence to GLP (Good Laboratory Practices), GDP (Good Documentation Practices), and cGMP (Current Good Manufacturing Practices) and is in the process of attaining EU-CEP and USFDA.
To place an order for Rivaroxaban, contact Bio-Synth through our customer service team or by filling out the contact form on our website. We provide comprehensive support to guide you through the order process and ensure timely delivery to meet your specific project needs.
